Yasushi Nakamura Selected Research

tryptophyl-proline

3/2014

Identification of antihyperuricemic peptides in the proteolytic digest of shark cartilage water extract using in vivo activity-guided fractionation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yasushi Nakamura Research Topics

Disease

50	Neoplasms (Cancer) 01/2019 - 01/2002
20	Breast Neoplasms (Breast Cancer) 01/2017 - 01/2002
16	Carcinoma (Carcinomatosis) 12/2018 - 06/2002
14	Lymphatic Metastasis 04/2014 - 02/2003
11	Neoplasm Metastasis (Metastasis) 12/2018 - 06/2002
9	Papillary Thyroid Cancer 01/2017 - 04/2003
8	Carcinogenesis 01/2018 - 11/2002
6	Colorectal Neoplasms (Colorectal Cancer) 12/2020 - 01/2008
6	Adenocarcinoma 03/2013 - 10/2002
6	Lymphoma (Lymphomas) 10/2006 - 01/2003
5	Colonic Neoplasms (Colon Cancer) 08/2020 - 03/2005
5	Body Weight (Weight, Body) 01/2019 - 03/2013
5	Stomach Neoplasms (Stomach Cancer) 02/2013 - 06/2002
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2019 - 04/2009
3	Thyroid Neoplasms (Thyroid Cancer) 01/2017 - 06/2005
3	Disease Progression 05/2012 - 06/2009
3	Papillary Carcinoma 10/2006 - 04/2003
2	Colitis 01/2019 - 11/2013
2	Urinary Bladder Neoplasms (Bladder Cancer) 01/2017 - 07/2011
2	Hepatocellular Carcinoma (Hepatoma) 12/2014 - 08/2014
2	Hepatitis 11/2013 - 07/2013
2	Hyperplasia 03/2013 - 12/2003
2	Pancreatic Neoplasms (Pancreatic Cancer) 04/2012 - 01/2008
2	Diabetic Retinopathy (Retinopathy, Diabetic) 10/2005 - 12/2002
2	Medullary Carcinoma 06/2005 - 01/2005
2	Chronic Thyroiditis 03/2004 - 01/2004
2	Ductal Carcinoma 11/2002 - 01/2002

Drug/Important Bio-Agent (IBA)

15	Proteins (Proteins, Gene)FDA Link 01/2017 - 11/2002
9	Messenger RNA (mRNA)IBA 11/2013 - 06/2002
7	Biomarkers (Surrogate Marker)IBA 01/2018 - 02/2003
6	Biological ProductsIBA 01/2019 - 11/2002
6	Cisplatin (Platino)FDA LinkGeneric 01/2017 - 04/2009
5	4-(methylthio)-3-butenyl isothiocyanateIBA 01/2019 - 03/2013
5	Estrogen ReceptorsIBA 12/2018 - 05/2002
5	Vascular Endothelial Growth Factor CIBA 04/2014 - 04/2003
5	Vascular Endothelial Growth Factor DIBA 11/2011 - 02/2003
4	AntibodiesIBA 12/2014 - 06/2002
4	NitritesIBA 11/2008 - 02/2006
4	Nitric Oxide (Nitrogen Monoxide)FDA Link 11/2008 - 02/2006
4	NitratesIBA 11/2008 - 02/2006
4	3-nitrotyrosineIBA 11/2008 - 02/2006
3	AcidsIBA 12/2020 - 09/2002
3	EstersIBA 12/2020 - 05/2008
3	pyroglutamylleucineIBA 01/2019 - 07/2013
3	Progesterone Receptors (Progesterone Receptor)IBA 12/2018 - 11/2003
3	Fluorouracil (Carac)FDA LinkGeneric 01/2017 - 01/2002
3	Gemcitabine FDA Link 01/2017 - 07/2011
3	CEACAM1 ProteinIBA 12/2014 - 08/2011
3	Protein Isoforms (Isoforms)IBA 12/2014 - 08/2011
3	ParaffinIBA 11/2002 - 06/2002
2	3-methylthiopropionateIBA 12/2020 - 05/2008
2	Immune Checkpoint InhibitorsIBA 01/2019 - 01/2019
2	Leucine (L-Leucine)FDA Link 01/2019 - 07/2013
2	LigandsIBA 01/2019 - 01/2018
2	Peptides (Polypeptides)IBA 01/2019 - 07/2013
2	Thyroglobulin FDA Link 12/2018 - 06/2009
2	CarcinogensIBA 01/2018 - 01/2004
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2015 - 12/2002
2	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 08/2014 - 03/2010
2	Chromogranin AIBA 07/2013 - 01/2009
2	Paclitaxel (Taxol)FDA LinkGeneric 02/2013 - 10/2006
2	Troleandomycin (TAO)FDA Link 01/2013 - 06/2009
2	Chemokine ReceptorsIBA 10/2012 - 05/2010
2	Small Interfering RNA (siRNA)IBA 04/2012 - 08/2011
2	Matrix Metalloproteinases (MMPs)IBA 02/2012 - 10/2006
2	Ethanol (Ethyl Alcohol)IBA 02/2012 - 01/2004
2	Neuropilin-2IBA 11/2011 - 07/2009
2	Hormones (Hormone)IBA 01/2011 - 12/2003
2	ChemokinesIBA 05/2010 - 04/2009
2	CXCR4 Receptors (CXCR4 Receptor)IBA 07/2009 - 11/2008
2	VimentinIBA 06/2009 - 06/2002
2	Connexin 43 (Connexin43)IBA 06/2009 - 03/2005
2	Pharmaceutical PreparationsIBA 04/2009 - 01/2003
2	Transcription Factors (Transcription Factor)IBA 05/2006 - 09/2003
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 11/2005 - 03/2004
2	Carrier Proteins (Binding Protein)IBA 06/2005 - 09/2003
2	Antineoplastic Agents (Antineoplastics)IBA 03/2005 - 01/2003
2	Polo-Like Kinase 1IBA 01/2005 - 01/2004
2	EnzymesIBA 12/2003 - 06/2002
2	Angiogenesis Inducing Agents (Angiogenesis Factor)IBA 04/2003 - 02/2003
2	RetinoidsIBA 04/2003 - 09/2002
2	fragile histidine triad proteinIBA 09/2002 - 09/2002
2	Thymidine PhosphorylaseIBA 02/2002 - 01/2002
2	Methotrexate (Mexate)FDA LinkGeneric 02/2002 - 01/2002
2	Tamoxifen FDA LinkGeneric 02/2002 - 01/2002
1	Volatile Oils (Essential Oils)IBA 08/2020
1	OxidesIBA 08/2020
1	piperitenoneIBA 08/2020
1	PlatinumIBA 01/2019
1	Antimicrobial PeptidesIBA 01/2019
1	Immune Checkpoint ProteinsIBA 01/2019

Therapy/Procedure

11	Therapeutics 01/2013 - 01/2002
8	Drug Therapy (Chemotherapy) 01/2019 - 02/2002
3	Adjuvant Chemotherapy 01/2019 - 04/2009
2	Oral Administration 01/2019 - 01/2018
2	Combination Drug Therapy (Combination Chemotherapy) 01/2017 - 07/2011
2	Radiotherapy 04/2012 - 08/2009
2	Pancreatectomy 01/2011 - 01/2008
2	Lasers (Laser) 04/2009 - 01/2004
2	Gastrectomy 01/2008 - 10/2006